Gene: C1orf159
Official Full Name: chromosome 1 open reading frame 159provided by HGNC
Gene Summary: Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19314 | C1orf159 Knockout cell line (HeLa) | Human | C1orf159 | 1:3~1:6 | Negative | Online Inquiry |
KO19315 | C1orf159 Knockout cell line (HCT 116) | Human | C1orf159 | 1:2~1:4 | Negative | Online Inquiry |
KO19316 | C1orf159 Knockout cell line (HEK293) | Human | C1orf159 | 1:3~1:6 | Negative | Online Inquiry |
KO19317 | C1orf159 Knockout cell line (A549) | Human | C1orf159 | 1:3~1:4 | Negative | Online Inquiry |
C1orf159 Gene Knockout Cell Lines are specialized human cell lines engineered to have a complete deletion of the C1orf159 gene, thus enabling the study of its function and the biological pathways in which it may be involved. This innovative product plays a crucial role in understanding gene function and regulation, particularly in areas related to cellular signaling, metabolic processes, and potential disease mechanisms.
The key functions of these knockout cell lines stem from the absence of C1orf159, allowing researchers to investigate the resultant phenotypic and molecular changes. By using CRISPR-Cas9 technology to precisely edit the genome, these cell lines serve as a powerful tool for analyzing gene interactions and cellular responses under various experimental conditions. They facilitate the study of gene dosage effects and metabolic pathways, providing insights into the roles of C1orf159 in health and disease.
Scientifically, C1orf159 Gene Knockout Cell Lines have significant applications in both research and clinical settings. They are invaluable in drug discovery, functional genomics, and understanding pathological mechanisms, particularly in cancer research and metabolic disorders. Researchers can utilize these cell lines to screen for novel therapeutics, study gene environment interactions, and explore the effects of various treatments on cellular behavior.
What sets our C1orf159 Gene Knockout Cell Lines apart from alternative products is their validated efficiency and reliability, coupled with robust characterization data. The specificity of the knockout minimizes off-target effects and ensures that observed phenotypic changes are attributable to the C1orf159 gene deletion. Additionally, our commitment to high-quality production standards guarantees consistent results across experiments.
In essence, the C1orf159 Gene Knockout Cell Lines represent a critical resource for advancing scientific knowledge and improving clinical outcomes. By providing researchers and clinicians with a more profound understanding of this gene’s role, we support their endeavors in precision medicine and innovative therapeutic strategies. Our company stands at the forefront of genetic engineering technologies, ensuring that our product offerings are backed by expertise and scientific rigor, empowering the research community to make significant strides in biological sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.